The reproductive organs and fetuses of seven Norwegian Red heifers were investigated for the presence of bovine viral diarrhea virus (BVDV) antigen during the time of initial transplacental transmission of the virus. The heifers were inoculated with a noncytopathogenic BVDV at day 85/86 of gestation and were slaughtered at day 7, 10, 14, 18, or 22 postinoculation (pi). Cryostat sections of uterus, ovaries, placentomes, intercotyledonary fetal membranes, and fetal organs were examined using immunohistochemical techniques. A double immunofluorescence technique was used to identify cells that showed staining with antibodies against the leukocyte common antigen CD45 or the intermediate filament vimentin and BVDV antigens. The earliest stage of infection at which BVDV antigen could be detected in the fetuses was 14 days pi. At this stage, BVDV antigen was detected in cells of mesenchymal origin in the lungs and in large cells that morphologically resembled immature megakaryocytes in the liver. In the intercotyledonary fetal membranes and in the placentomes, BVDV antigen was not detected until 18 and 22 days pi, respectively. BVDV antigen was not detected in maternal tissue from any of the heifers. The present results indicate that fetal infection with BVDV can take place without preceding or simultaneous high concentrations of BVDV in uterus or placenta of acutely infected heifers.
In susceptible pregnant animals, bovine viral diarrhea virus (BVDV) readily crosses the placenta and infects the fetus. 10, 28 The outcome of the fetal infection depends on the properties of the virus and on the stage of gestation at which the dam is infected. 30 Only the noncytopathogenic biotype of the virus has been reported to establish a persistent infection in the fetus. In cattle, a persistent infection with BVDV-specific immunotolerance can occur when a susceptible dam is infected with BVDV from approximately day 30 of gestation or even earlier 23 and until the fetus establishes immunocompetence against BVDV around day 120 of gestation. Although fetal infection during this period of gestation may also result in fetal death, abortion, mummification, malformations, or stillbirth, 9, 10, 22, 24, 36 apparently healthy animals immunotolerant to and persistently infected with BVDV are of great concern for cattle populations because these cattle continue to shed large amounts of virus as long as they live and, accordingly, are very important in the epidemiology of BVDV infections. 19 Even if the outcome of fetal infection with BVDV is well recognized, the effect of the virus on the placenta and the rate and manner in which the virus crosses the placenta and infects the fetus have not been established. Most researchers have concluded that there are only minor or no lesions in the placentomes after experimental infection of cattle with BVDV 10, 22 or after abortions where BVDV is suspected as the causative agent. 31 In other studies performed in pregnant sheep, prominent lesions have been discovered in the placentomes after experimental infection. 32, 41 The discrepancies among the results of these studies may to some extent be explained by the use of different strains or biotypes or even mixtures of different pestiviruses. It is still unclear whether fetal death and abortions follow directly from viral invasion of the fetuses or whether they are caused by damage to the maternal placenta that disrupts the vascular supply of nutrients. 7 The tropism of BVDV for lymphoid, neural, and epithelial tissues has been demonstrated; 1, [3] [4] [5] 15, 18 however, most studies of viral distribution have been focused on postnatal persistently infected animals, and the presence of virus in the uterus, placenta, and fetus during the time of initial transplacental infection has received less attention. The placenta has been considered the organ of choice for virus replication, 41 and both maternal and fetal epithelial cells of uterus, placentomes, and intercotyledonary fetal membranes have Fredriksen, Press, Sandvik, Ødegaard, and Løken been shown to be infected in persistently infected heifers. 16 Thus, direct cell-to-cell transmission may represent the pathway for transplacental infection of the fetus. Alternatively, transplacental infection with BVDV may occur via a vascular pathway. To investigate the possible routes of fetal infection with BVDV, and in particular the involvement of the placentomes, immunohistochemical techniques were used to determine the time of appearance and the cellular localization of viral antigens in the uterus, placenta, fetal membranes, and some fetal organs in heifers during an acute experimental infection with a noncytopathogenic BVDV in early pregnancy.
Materials and Methods

Animals and inoculation
Eight pregnant heifers of the Norwegian Red breed were housed in an isolation unit at the Norwegian School of Veterinary Science during the experiment. The heifers had been inseminated with semen from a certified artificial insemination center (Norwegian Cattle Association, Hamar, Norway) where all bulls have tested free from BVDV since 1985. The heifers were all shown to be free from BVDV by an antigen enzyme-linked immunosorbent assay (ELISA) performed on blood leukocytes 38 and by virus isolation in cell cultures. 25 They were free from serum neutralizing antibodies to BVDV at the beginning of the experiment. Seven of the animals (heifer Nos. 1-7) were inoculated intramuscularly with BVDV at day 85/86 of gestation and slaughtered 7, 10, 14, 14, 18, 18, or 22 days postinoculation (pi), respectively. The remaining animal served as a negative control and was given an intramuscular inoculation with 5 ml of a cell culture medium at day 85 of gestation and slaughtered 14 days later (heifer No. 8). One pregnant uterus at a comparable stage of gestation was collected from a heifer at the abattoir and used as an additional negative control (heifer No. 9).
Inoculum
The virus used was a noncytopathogenic BVDV isolated in 1993 from a persistently infected but clinically healthy Norwegian heifer (No. 93/4618-226). 37 Partial nucleotide sequencing of the 5Ј untranslated region of this isolate showed greatest homology to type-1 BVDVs of European origin (unpublished data). Because field isolates may consist of several strains, the virus was biologically cloned three times by endpoint titrations in fetal bovine kidney cell cultures from which the inoculum was harvested at a concentration of 10 4.4-4.9 CCID 50 /ml in Eagle's minimal essential medium. Each animal was inoculated with approximately 10 4 CCID 50 BVDV diluted with saline to a volume of 5 ml.
Clinical, virologic, serologic, and hematologic examinations
The animals were examined clinically twice daily from inoculation to slaughter. Rectal temperature, appetite, the presence of a nasal and/or vaginal discharge, and the consistency of the feces were recorded. Blood samples were collected daily, and serum was examined for BVDV by in-oculation of fetal bovine kidney cell cultures, which subsequently were immunostained for noncytopathogenic BVDV. 25 Serum samples obtained twice weekly were examined for antibodies to BVDV using a commercial indirect ELISA kit (Svanovir, SVANOVA, Uppsala, Sweden). 21 Leukocyte and platelet counts and electrophoresis of serum proteins were also performed with samples collected twice weekly.
Postmortem examination and collection of tissue specimens
At slaughter of the heifers, the uterus, ovaries, placentomes, fetal membranes, and fetuses were examined grossly. Fetal blood samples were collected for virus isolation in cell cultures 25 or for examination with a reverse-transcriptase nested polymerase chain reaction (RT-PCR). 39 The serum samples were also examined for antibodies to BVDV using the ELISA kit. 21 Tissues for immunohistochemical examination were collected from the liver, lung, spleen, brain, and intestine of the fetuses, the ovaries and uterus of the heifers, and the placentomes and intercotyledonary fetal membranes (chorioallantois and/or amniochorion) using sterile disposable equipment. Tissue samples were embedded in Tissue-Tek OCT compound (4583, Miles, Elkhart, IN) and frozen in chlorodifluoromethane chilled in liquid nitrogen, wrapped in aluminum foil, and stored at Ϫ70 C. Sections (6-8 m thick) were cut with a cryostat and mounted on glass slides precoated with glycerol or poly-L-lysine (P8920, Sigma Chemical Co., St. Louis, MO). Tissue from the fetal livers, spleens, and lungs were also frozen at Ϫ70 C and tested for BVDV in cell cultures 25 and with RT-PCR. 39 
Immunohistochemical investigations
An avidin-biotin-peroxidase complex method (ABC-PO, Vectastain ABC kit, Vector Laboratories, Burlingame, CA) was used to examine sections from all samples. In addition, an indirect immunofluorescence technique and a double immunofluorescence technique were used as previously described. 16 For both the immunoperoxidase and the immunofluorescence techniques, a mixture of five commercially available murine monoclonal antibodies (WB 160, WB 162, WB 210, WB 215, and WS 363, Central Veterinary Laboratory, Weybridge, UK) was used as the primary antibody for demonstration of BVDV antigens. This mixture, which contains four antibodies of isotype IgG 1 and one of isotype IgG 2b , is expected to detect most isolates of BVDV and border disease virus. 13 A mixture of two other monoclonal antibodies (13G4 and VPM20, Moredun Animal Health, Edinburgh, UK) of isotype IgG 2a against the nonstructural p125/p80 polypeptide of BVDV was also used on some sections with the ABC-PO method. 12, 14 The double immunofluorescence technique used isotype-specific secondary antibodies to distinguish between a murine monoclonal IgG 2a antibody against the leukocyte common antigen CD45 (SBU-LCA) or a murine monoclonal IgG 2a antibody against the intermediate filament vimentin (3B4, M7020 Dako, Denmark) and the mixture of BVDV antibodies. The isotypespecific secondary antibody used to detect the BVDV antibody mixture would not detect the BVDV antibody with the IgG 2b isotype. For each organ examined, equivalent sections 
† PCR ϭ reverse-transcriptase nested polymerase chain reaction. ‡ Including liver, lung, and/or spleen. § n.d. ϭ not done. Lung was positive, liver was negative. # For these samples, the parallel negative control cell cultures were also positive.
¶ Lung and spleen were weakly positive; liver was negative.
from persistently infected animals 16 were used as positive controls. As a negative control for the immunohistochemical procedures, the primary antibodies were excluded from the tissue sections.
Results
Clinical findings
All experimentally infected animals except one had a moderate rise in body temperature for Ն1 day. Four of the animals had a slight nasal discharge for a few days, and two had a cough for 1-2 days. Appetite and feces remained normal throughout the experiment, and vaginal discharge was not observed from any of the animals. The control animal remained healthy throughout the study. The concentrations of serum proteins and the gamma globulin fraction remained stable throughout the experiment for all animals. Leukocyte and platelet counts were within normal range.
Virology and serology
The results are summarized in Table 1 . Microscopic examination of immunostained cell cultures revealed BVDV in blood from five of the heifers between days 5 and 7 pi. Antibodies against BVDV were not demonstrated until days 13-16 pi, with increasing antibody levels in subsequent samples. The control animal (No. 8) remained both virus and antibody negative until slaughter.
In the fetal samples, BVDV was demonstrated by virus isolation in one or more organs from the fetuses surviving until day 14 pi. For the organ samples examined by RT-PCR, the results were in accordance with those of virus isolation except for the lung sample from the fetus examined at day 7 pi (heifer No. 1), which was positive for BVDV with RT-PCR but negative with virus isolation. The organs of the fetus examined 10 days pi (heifer No. 2) and the abattoir control (No. 9) were negative for BVDV both in cell cultures and with RT-PCR. The fetal organ samples from the control animal (No. 8) were positive for BVDV by isolation in cell cultures, and the lung and spleen samples were weakly positive also with RT-PCR, but the liver sample was negative. For virus isolation, samples from the control animal were examined in a set-up where the parallel negative control cell cultures were also positive. Because of this fetal blood samples corresponding to the affected samples were examined by RT-PCR; heifer No. 8 (control) was negative and heifer Nos. 5 and 6 (both day 18 pi) were positive. All fetal blood samples tested were negative for antibodies to BVDV.
Pathologic findings
Gross morphologic changes were not detected in the uterus or its contents from any of the animals. One of the heifers (No. 6) carried twins.
Immunohistochemical investigations
The results for both mixtures of BVDV antibodies used in the immunoperoxidase technique and for the immunofluorescent staining are given in Table 2 ; the results of the double immunofluorescent staining are given in Table 3 . BVDV antigens were not detected in cryosections from the ovaries or uterus from the heifers or from the maternal part of the placentomes (the caruncles) from any of the animals. None of the sec- tions from the control animals or the animals slaughtered 7 or 10 days pi showed any specific staining. The two mixtures of BVDV antibodies both gave specific staining in all organs when used on samples from persistently infected animals. In the samples from the two animals slaughtered 14 days pi, BVDV-positive cells were detected in the lungs of both fetuses and in the liver of one fetus (heifer No. 3). In this liver, only large cells negative for both CD45 and vimentin and that morphologically resembled immature megakaryocytes were positive for BVDV. In the lungs, most virus-positive cells were positive for vimentin and negative for CD45 ( Fig. 1) .
For the two fetuses collected 18 days pi, reactivity for BVDV was detected in the spleen, brain, and intestine and in the intercotyledonary fetal membranes. There was a large increase in the proportion of BVDVpositive cells in the fetal liver and lungs compared with the proportion in these organs in fetuses collected 14 days pi. At 18 and 22 days pi, epithelial cells in the lungs also showed reactivity for BVDV ( Fig. 2) , as did smooth muscle cells in the tunica media of blood vessels. Both epithelial and nonepithelial cells in the fetal intestine showed reactivity for BVDV. The nonepithelial BVDV-positive cells were mainly localized in the lamina propria and were positive for vimentin but negative for CD45. In the liver, lymphocytelike cells that also showed reactivity for CD45 were positive for BVDV at this stage. The hepatocytes did not show reactivity for BVDV. In the spleen, many cells showed reactivity for BVDV at 18 and 22 days pi. These cells were negative both for CD45 and for vimentin. Many platelets showed reactivity for BVDV. Large BVDV-positive cells that resembled immature megakaryocytes were also present in the spleen (Fig.  3) .
In the fetal membranes, mostly small vessels and subepithelial cells stained for BVDV ( Fig. 4 ). These cells also showed reactivity for vimentin but not for CD45. A few epithelial cells, both in the chorion and in the amnion/allantois, also showed staining for BVDV.
BVDV antigen was demonstrated in the placentomes only in the animal slaughtered 22 days pi ( Fig.  5 ). Small vimentin-positive cells on the fetal side of the fetomaternal interface were the main cell population that stained for BVDV. Occasionally, CD45-positive fetal cells in the placentomes showed reactivity for BVDV antigen. In the other organs, the results at 22 days pi were similar to the results seen at 18 days pi, but in most organs the presence of cells showing staining for BVDV had increased.
Discussion
In the present study, the earliest stage of infection at which BVDV antigen was detected in fetal or uter- ine tissues using immunohistochemical techniques was 14 days after inoculation of the heifers. At this early stage of infection, scattered clusters of BVDV-infected cells were detected in fetal liver and lung only. In the intercotyledonary fetal membranes and the placentomes, BVDV was not detected until days 18 and 22 pi, respectively. In most studies where fetal infection has been investigated, early transfer of virus has not been addressed. However, in one study, BVDV was detected in ovine fetal tissues 7 days after inoculation of pregnant ewes, 32 and in another the time of fetal death in cattle was determined to be from 12 days pi with BVDV. The time of virus transfer from the mother to the fetus is probably influenced by virus strain, host species, and individual variation. In the present study, intramuscular inoculation was used to reduce possible individual variation in the time from virus exposure to viremia so that the time from inoculation of the heifers to detection of virus in the placenta and fetus in the different animals could be compared. The detection of a fetal infection with BVDV at 10-14 days pi in the present study was supported by the results of conventional virologic examination of fetal organs, which did not reveal virus before 14 days pi. The positive RT-PCR results for the fetus euthanatized at 7 days pi were obtained with the lung sample, but the liver sample was negative. RT-PCR is a sensitive assay for viral RNA 6 and accordingly is susceptible to contamination, resulting in false-positive results. Thus, the significance of the positive RT-PCR result on day 7 pi for the lung sample remains to be determined. Contamination would appear to be the most reasonable explanation for the positive results of the virus examinations of some of the fetal organs of the negative control (heifer No. 8). In the RT-PCR, the fetal liver was negative and the fetal spleen and lung were only weakly positive as compared with the other positive samples. Blood samples from the heifer (heifer No. 8) and her fetus were both negative when tested with RT-PCR. In addition, a cell culture line was established from turbinate cells of the fetus and has proven to be negative for BVDV (data not shown).
The validity of the immunohistochemical approaches was supported by the general consistency in results achieved with different immunohistochemical techniques. In addition, both mixtures of BVDV antibodies did not identify viral antigens in uterus, placentomes, or intercotyledonary fetal membranes at 14 days pi or in the liver of heifer No. 3. Further, the immunohistochemical and virologic methods showed a similar sensitivity in fetal and maternal tissues. However, although viral antigen was not detected immunohistochemically in tissue from the heifers during an acute experimental infection in the present study, other investigators have demonstrated BVDV antigen in the Fig. 1B . Same section showing cells staining for BVDV (yellow) and for CD45 (red). One CD45ϩ cell identified in Fig. 1B is also weakly stained for BVDV ( Fig. 1A, arrow) , whereas the other CD45ϩ cells show no reactivity for virus antigen. tissues of animals experimentally infected with noncytopathogenic BVDV. 27, 42, 44 In these other studies, BVDV antigens were detected predominantly in lymphoid tissues while uterus, placenta, and ovaries were not examined. Thus, a direct comparison with the present results is not possible. The observed lack of staining in the maternal tissues is in accordance with the negative results of virus isolation from uterine tissues and indicates that the passage of virus to the fetus occurs without high concentrations of virus in uterine tissue. Alternatively, high virus concentration in uterus may have been of very short duration and therefore not detected in the present study.
Epithelial cells and certain leukocyte populations have been shown to be predilection sites for BVDV replication. 3, 5, 29 In the present study, the expression of the leukocyte common antigen CD45 was used to identify cells of a hemopoietic origin. 2, 26 However, virus-infected CD45ϩ cells were only consistently demonstrated in the fetal liver. Another phenotypic marker of cell populations investigated in the present study was the expression of the intermediate filament vimentin. The presence of vimentin was used to provide an indication of the mesenchymal origin of virus-infected cells. The expression of intermediate filaments in embryonal and fetal cells changes during development and is less stable than in mature cells. 17 The functions of intermediate filament proteins have been considered related to the specific functions of differentiated cells rather than to cell growth and division, and these proteins were not present in rapidly dividing cells. 11 The present study did not address the cell cycle status of virus-infected cells. In all the organs studied, some nonepithelial BVDV-positive cells were negative for both vimentin and CD45. The absence of these markers suggests that the viral antigen-containing cells were probably undifferentiated cells. Previous studies in calves and heifers have found differentiated leukocyte populations such as B-cells, T-cells, and null cells to be major virus-infected cell populations. 4, 27, 44 At the earliest stages of fetal infection, 14 days pi, viral antigen was readily detected in fetal organs but was not detected in the placentomes. At 22 days pi, viral antigen was weakly present in the cotyledons.
The sparsity of viral antigen suggests that the fetal placenta is not a predilection site for virus replication early in fetal infection. Some studies have reported high titers of BVDV in placental tissue, 32, 40, 41 but none of these studies were performed on acutely infected cattle. Based on the presence of high virus titers in ovine placentomes, the placentome appeared to be the organ of choice for virus multiplication. 41 However, the pregnant ewes were inoculated with BVDV isolated from outbreaks of mucosal disease, but it is unclear whether the cytopathogenic virus used was free from contamination with noncytopathogenic BVDV. 41 In addition, the virus strain used was known to be more pathogenic than several other strains. Similarly, a high virus titer was reported in placental tissue after infection with a virus isolated from a fatal case of mucosal disease. 40 In a previous study, the maternal crypt epithelium in placentomes from persistently infected animals was confirmed to be heavily infected, whereas only scattered cells in the cotyledons showed staining for BVDV antigen. 16 In the placentomes of persistently infected animals, however, the main cell population showing reactivity for BVDV was a binuclear trophoblast cell, whereas in the acutely infected animal (No. 7) in the present study, mainly small cells of mesenchymal origin were infected.
In the acutely infected animals, the distinct staining of cells in chorioallantois/amniochorion 18 days pi is notable in relation to the absence of staining in the placentomes at this stage and the difference in the distribution of BVDV-positive cells compared with that shown in persistently infected heifers. 16 In the fetal membranes of persistently infected animals, only scattered cells of mesenchymal origin showed reactivity for BVDV, whereas a high proportion of the epithelial cells in the chorion was affected. In the present study with acutely infected animals, the main cell population showing reactivity for BVDV was of mesenchymal origin, and epithelial cells only occasionally showed reactivity for BVDV. The observed differences between the two studies may be due to the BVDV infection status of the dams, although the possibility that the differences are a consequence of the time interval from the initial fetal infection seems more likely. This pos-sibility is supported by the results of the immunohistochemical staining of fetal lungs, in which the distribution of BVDV antigen in samples collected 22 days pi resembled that in similar sections from the persistently infected animals but was different in the earlier stages of acute infection. Further studies of placentomes and intercotyledonary fetal membranes from acutely infected dams are needed to determine the basis for these observed differences.
A possible route of passage for the virus from dam to fetus could be via uterine secretions to the chorion. However, most BVDV-positive cells seen at the earliest stages of infection were subepithelial cells of mesenchymal origin and not epithelial cells, which does not indicate the transfer of infection via the uterine secretions. BVDV has been thought to have a predilection for vascular endothelial cells, and virus replication in these cells could result in vascular damage facilitating the spread of the virus across the placenta. 43 The initial detection of BVDV-positive cells in fetal liver and lung 14 days pi without simultaneous detection of virus in the placenta supports the proposition that the passage of virus has taken place via the vasculature and not via local cell-to-cell spread.
The pathogenic effect of BVDV infection on the placenta is a point of contention. Most authors have concluded that only minor or no lesions are found in the placenta after infection of the bovine fetus, 10, 20, 22 whereas others have reported lesions in the ovine placenta. 32, 41 Lesions in placenta have not been reported after infection with noncytopathogenic BVDV. Although histologic examination of the placenta was not included in the present study, the presence of a heavy infection of fetal organs without simultaneous detection of BVDV antigen in the placenta indicates that a fetal infection with noncytopathogenic BVDV can occur in the absence of significant levels of virus in the placenta.
The fetal cells that were shown to be infected with BVDV at the earliest stage of infection were probably immature megakaryocytes in the liver and cells of mesenchymal origin in the lungs. Many platelets in the spleen were also infected with BVDV at an early stage of infection. BVDV has previously been demonstrated in megakaryocytes of acutely infected calves, 27, 42 which could be of importance for the pathogenesis of thrombocytopenia in calves acutely infected with virulent noncytopathogenic strains of BVDV. 35 These strains are characterized as atypical or type-2 BVDV, 33, 34 which are antigenically different from the classic or type-1 BVDV strains. The present results indicate that the megakaryocytes may have an important role also in the initial stages of intrauterine infection in acutely infected dams and the production of persistently infected calves. However, further investigations are needed to clarify the role of megakaryocytes in the pathogenesis of BVDV infection of the fetus.
